Investigates Bayesian group testing models, indicating efficacy in detecting illnesses.
We propose a Bayesian model to investigate a group testing regression model of equally- sized subgroups. The group testing design was developed by Dorfman (1943) to reduce costs and increase efficiency when detecting illnesses in populations and can be used to detect contamination in samples, when prevalence is low enough. We develop a Laplace-Bernstein- von Mises (BvM) Theorem in the style of Le Cam (1986), where distributional convergence to a Gaussian holds in total variation distance almost surely, and we list sufficient conditions. We also deduce additional conditions to derive a strong BvM for the group testing posterior distribution.
No takes yet. Share an insight, caveat, or question.
Jonathan Kunick (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: